ASK REDCHAT ANYTHING ABOUT ALZAMEND NEURO INC.
Alzamend Neuro Inc. (NASDAQ: ALZN)
Listen to this Section
$1.11
-0.0300
(
-2.63% )
10.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| AL001DetailsAlzheimer's disease |
Phase 2 |
| AL001DetailsMajor depressive disorder |
Phase 2 |
| AL001DetailsPost-traumatic stress disorder |
Phase 2 |
| AL001DetailsBipolar disease |
Phase 2 |
| ALZN002DetailsAlzheimer's disease, Dementia |
Phase 1/2 |
Market Data
|
| Open |
$1.11 |
| Previous Close |
$1.14 |
| Volume |
10.2K |
| Market Cap |
$4.38M |
| Day Range |
$1.10 - $1.15 |
| 52 Week Range |
$0.84 - $4.00 |
| Shares Outstanding |
3.80M |
| Change % |
-2.63% |
| Net Change |
▼ -0.0300 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Medicinal Chemicals and Botanical Products |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | Spartan Capital Securities, more |
Insider Ownership Transactions
Total Amount Purchased:
-597,534.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-14 |
Buy |
75.00 |
AULT MILTON C III |
| 2024-08-01 |
Buy |
25.00 |
AULT MILTON C III |
| 2024-04-23 |
Buy |
1000.00 |
AULT MILTON C III |
| 2024-04-03 |
Buy |
334.00 |
AULT MILTON C III |
| 2024-04-01 |
Buy |
2000.00 |
AULT MILTON C III |
| 2024-03-28 |
Buy |
780.00 |
AULT MILTON C III |
| 2024-02-02 |
Buy |
1220.00 |
AULT MILTON C III |
| 2024-01-25 |
Sale |
-661168.00 |
AULT MILTON C III |
| 2024-01-09 |
Buy |
5000.00 |
AULT MILTON C III |
| 2023-12-27 |
Buy |
200.00 |
AULT MILTON C III |